Jefferies maintains Telesis Bio at 'buy' with a price target of $4.00

  • Investing.com
Jefferies maintains Telesis Bio at 'buy' with a price target of $4.00

An analyst from Jefferies maintained Telesis Bio (NASDAQ: TBIO ) at 'buy' with a price target of $4.00 from a prior price target of $5.00.

Prior to this rating, Telesis Bio had 2 buy ratings, 1 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Telesis Bio, click here. For more news on Telesis Bio, click here.

Telesis Bio's stock price closed at $1.39. They are down -14.2% in the last month and down -41.10% in the last 12 months.

According to Investing Pro, Telesis Bio's fair value is $1.90, an upside of 36.41%. Telesis Bio's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out Telesis Bio's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100